| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/30/2010 | WO2010111460A1 Inhibitors of nf-kb |
| 09/30/2010 | WO2010110409A1 Process for producing pyrone and pyridone derivatives |
| 09/30/2010 | WO2010110353A1 Novel amide derivative and skin whitening agent |
| 09/30/2010 | WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative |
| 09/30/2010 | WO2010108608A1 Substituted piperidines as par-1 antagonists |
| 09/30/2010 | WO2010108584A1 Synthesis of n-substituted furan-2(5h)-ones |
| 09/30/2010 | US20100249205 Metabolites of Wortmannin Analogs and Methods of Using Same |
| 09/30/2010 | US20100249181 HIV Protease Inhibiting Compounds |
| 09/30/2010 | US20100249176 Heterocycle amide t-type calcium channel antagonists |
| 09/30/2010 | US20100249175 Dicationic compounds which selectively recognize G-quadruplex DNA |
| 09/30/2010 | US20100249161 2- ( 2 -hydroxyphenyl) -quinazolin-4-ones useful for treating obesity and diabetes |
| 09/30/2010 | US20100249159 Rho-kinase inhibitors |
| 09/30/2010 | US20100249129 Compounds as cannabinoid receptor ligands |
| 09/30/2010 | US20100249113 Modulators of atp binding cassette transporters |
| 09/30/2010 | US20100249097 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments |
| 09/30/2010 | US20100249094 Compounds for the Treatment of Hepatitis C |
| 09/30/2010 | US20100249092 Heteroaryl compounds and uses thereof |
| 09/30/2010 | US20100249049 Arylalkylamine compound and process for preparing the same |
| 09/30/2010 | US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 09/30/2010 | DE102009014484A1 Substituierte Piperidine Substituted piperidines |
| 09/30/2010 | CA2756376A1 Process for the preparation of doxazosin and salts thereof |
| 09/30/2010 | CA2756255A1 Substituted bicyclic hcv inhibitors |
| 09/30/2010 | CA2756178A1 Compounds as cannabinoid receptor ligands |
| 09/30/2010 | CA2756172A1 Inhibitors of hepatitis c virus replication |
| 09/30/2010 | CA2756005A1 Substituted piperidines as par-1 antagonists |
| 09/30/2010 | CA2755910A1 Inhibitors of nf-kb |
| 09/30/2010 | CA2755348A1 Antiviral compounds and uses thereof |
| 09/29/2010 | EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
| 09/29/2010 | EP2233470A1 Histamine H3 receptor antagonists |
| 09/29/2010 | EP2231679A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
| 09/29/2010 | EP2231646A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists |
| 09/29/2010 | EP2231640A1 Beta-amino acid derivatives for treatment of diabetes |
| 09/29/2010 | EP2231638A1 Phthalazinone derivatives |
| 09/29/2010 | EP2231620A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation |
| 09/29/2010 | EP2231611A1 Novel 2-pyrrolidinyl-3-amido-6-amino-pyridine derivatives useful as potassium channel activators |
| 09/29/2010 | EP2231606A2 Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids |
| 09/29/2010 | EP2231602A1 Gamma secretase modulators |
| 09/29/2010 | EP2231600A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| 09/29/2010 | EP2231558A1 3,4-substituted pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 09/29/2010 | EP1638957B1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 09/29/2010 | EP1628957B1 Sulfopyrroles |
| 09/29/2010 | EP1615889B1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1086950B1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |
| 09/29/2010 | CN101848898A Phthalazinone derivatives as inhibitors of PARP-1 |
| 09/29/2010 | CN101848897A Gamma secretase modulators |
| 09/29/2010 | CN101845016A Method for synthesizing derivatives of chiral tetrahydroquinoline by catalyzing asymmetric hydrosilylation with iridium |
| 09/29/2010 | CN101061110B Heterlcyclic diamide insecticides |
| 09/29/2010 | CN101006082B Histamine H3 receptor agents, preparation and therapeutic uses |
| 09/29/2010 | CN101006076B Modulators of ATP-binding cassette transporters |
| 09/28/2010 | US7803944 Viral polymerase inhibitors |
| 09/28/2010 | US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 09/28/2010 | US7803841 EP2 receptor agonists |
| 09/28/2010 | US7803836 (3-{[4-amino-3-(1-cyclopentyl-pyrrolidin-3-ylamino)-benzenesulfonyl]-isobutyl-amino}-1-benzyl-2-hydroxy-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; active against wild-type HIV and show broad-spectrum activity against mutant HIV exhibiting resistances against known protease inhibitors |
| 09/28/2010 | US7803831 3-(2-hydroxy-phenyl)-1H-pyrazole-4-carboxylic acid amide derivatives as HSP90 inhibitors for the treatment of cancer |
| 09/28/2010 | US7803814 Tricyclic steroid hormone nuclear receptor modulators |
| 09/28/2010 | US7803813 selective serotonin receptor agonists, such as 2-chloro-4-fluoro-N-(3-(1-methylpiperidin-4-ylamino)phenyl)benzamide fumarate, used fot the treatment or prevention of neuronal protein extravasation and/or headaches |
| 09/28/2010 | US7803807 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
| 09/28/2010 | US7803795 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis |
| 09/28/2010 | CA2527587C Heteroaryl-substituted imidazole derivatives as glutamate receptor antagonists |
| 09/28/2010 | CA2527129C Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 09/28/2010 | CA2481707C Benzopyran derivatives substituted with secondary amines having tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 09/28/2010 | CA2395772C Sulfonamide-containing heterocyclic compounds |
| 09/28/2010 | CA2387016C Acrylamide derivatives as fab i inhibitors |
| 09/28/2010 | CA2383524C Thiazolyl alkynyl compounds and methods of use thereof |
| 09/28/2010 | CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans |
| 09/28/2010 | CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis |
| 09/23/2010 | WO2010107115A1 Glycine transporter inhibitor |
| 09/23/2010 | WO2010106097A1 Substituted pyrimidines for the treatment of cancer |
| 09/23/2010 | WO2010105779A1 Novel method for producing enaminocarbonyl compounds |
| 09/23/2010 | WO2010105772A1 Novel method for producing enaminocarbonyl compounds |
| 09/23/2010 | WO2009065897A3 Inhibitors of malt1 proteolytic activity and uses thereof |
| 09/23/2010 | US20100240725 Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation |
| 09/23/2010 | US20100240707 1,3,5-trisubstituted triazole derivative |
| 09/23/2010 | US20100240706 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones |
| 09/23/2010 | US20100240705 Substituted enaminocarbonyl compounds used as insecticides |
| 09/23/2010 | US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors |
| 09/23/2010 | US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application |
| 09/23/2010 | US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 09/23/2010 | US20100240650 Substituted pyrrolines as kinase inhibitors |
| 09/23/2010 | US20100240639 Sulfonyl-Derivatives as Novel or Histone Deacetylase |
| 09/23/2010 | US20100239496 Imaging agents for detecting neurological disorders |
| 09/23/2010 | CA2755759A1 Substituted pyrimidines for the treatment of cancer |
| 09/22/2010 | EP2230237A1 New method for producing enaminocarbonyl compounds |
| 09/22/2010 | EP2230236A1 New method for producing enaminocarbonyl compounds |
| 09/22/2010 | EP2229376A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 09/22/2010 | EP2229356A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| 09/22/2010 | EP1836163B1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 09/22/2010 | EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/22/2010 | EP1618092B1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors |
| 09/22/2010 | EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 09/22/2010 | CN1976705B 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1H-pyrrolo not 2,3-C|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and dia |
| 09/22/2010 | CN1788001B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/22/2010 | CN101842369A 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases |
| 09/22/2010 | CN101842360A Anti-infective pyrimidines and uses thereof |
| 09/22/2010 | CN101838271A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 09/22/2010 | CN101838239A Pyrazole compound as well as composition and application thereof |
| 09/22/2010 | CN101837127A Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 09/21/2010 | US7799922 adenosine A3 receptor antagonists; improved bioavailability; treatment of diseases such as asthma, COPD and ARDS, glaucoma, tumor, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases; e.g. 4-Methoxy-N-[6-(morpholin-4-yl)-4-benzylamino-3-cyanoquinolin-2-yl]-benzamide |
| 09/21/2010 | US7799916 reacting 5-bromobenzofuran-2-carboxamide with 3-(4-piperazin-1-ylbutyl)indole-5-carbonitrile by transition-metal-catalysed coupling by means of a Pd complex (tris(dibenzylideneacetone)-dipalladium to form 5-(4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl)benzofuran-2-carboxamide; reductive amination |